|
1
|
Gatto M, Bragazzi MC, Semeraro R, Napoli
C, Gentile R, Torrice A, Gaudio E and Alvaro D: Cholangiocarcinoma:
Update and future perspectives. Dig Liver Dis. 42:253–260. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tyson GL and El-Serag HB: Risk factors for
cholangiocarcinoma. Hepatology. 54:173–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Van Beers BE: Diagnosis of
cholangiocarcinoma. HPB (Oxford). 10:87–93. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ghouri YA, Mian I and Blechacz B: Cancer
review: Cholangiocarcinoma. J Carcinog. 14:12015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Carbone PP, Kaplan HS, Musshoff K,
Smithers DW and Tubiana M: Report of the Committee on Hodgkin's
Disease Staging Classification. Cancer Res. 31:1860–1861.
1971.PubMed/NCBI
|
|
6
|
Wollner N, Burchenal JH, Lieberman PH,
Exelby P, D'Angio G and Murphy ML: Non-Hodgkin's lymphoma in
children. A comparative study of two modalities of therapy. Cancer.
37:123–134. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sacchi S, Marcheselli L, Bari A,
Marcheselli R, Pozzi S, Luminari S, Lombardo M, Buda G, Lazzaro A,
Gobbi PG, et al: Secondary malignancies after treatment for
indolent non-Hodgkin's lymphoma: A 16-year follow-up study.
Haematologica. 93:398–404. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Travis LB, Curtis RE, Boice JD Jr, Hankey
BF and Fraumeni JF Jr: Second cancers following non-Hodgkin's
lymphoma. Cancer. 67:2002–2009. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Travis LB, Curtis RE, Glimelius B,
Holowaty E, van Leeuwen FE, Lynch CF, Adami J, Gospodarowicz M,
Wacholder S and Inskip P: Second cancers among long-term survivors
of non-Hodgkin's lymphoma. J Natl Cancer Inst. 85:1932–1937. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu XG, Bednarz B and Paganetti H: A review
of dosimetry studies on external-beam radiation treatment with
respect to second cancer induction. Phys Med Biol. 53:R193–R241.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tubiana M: Can we reduce the incidence of
second primary malignancies occurring after radiotherapy? A
critical review. Radiother Oncol. 91:4–15. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cahan WG and Woodard HQ: Sarcoma arising
in irradiated bone; report of eleven cases. Cancer. 1:3–29. 1948.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mudie NY, Swerdlow AJ, Higgins CD, Smith
P, Qiao Z, Hancock BW, Hoskin PJ and Linch DC: Risk of second
malignancy after non-Hodgkin's lymphoma: A British cohort study. J
Clin Oncol. 24:1568–1574. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brennan P, Coates M, Armstrong B, Colin D
and Boffetta P: Second primary neoplasms following non-Hodgkin's
lymphoma in New South Wales, Australia. Br J Cancer. 82:1344–1347.
2000.PubMed/NCBI
|
|
15
|
Dores GM, Curtis RE, van Leeuwen FE,
Stovall M, Hall P, Lynch CF, Smith SA, Weathers RE, Storm HH,
Hodgson DC, et al: Pancreatic cancer risk after treatment of
Hodgkin lymphoma. Ann Oncol. 25:2073–2079. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Morton LM, Dores GM, Curtis RE, Lynch CF,
Stovall M, Hall P, Gilbert ES, Hodgson DC, Storm HH, Johannesen TB,
et al: Stomach cancer risk after treatment for hodgkin lymphoma. J
Clin Oncol. 31:3369–3377. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andersson M and Storm HH: Cancer incidence
among Danish Thorotrast-exposed patients. J Natl Cancer Inst.
84:1318–1325. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Kaick G, Dalheimer A, Hornik S, Kaul
A, Liebermann D, Lührs H, Spiethoff A, Wegener K and Wesch H: The
german thorotrast study: Recent results and assessment of risks.
Radiat Res. 152:S64–S71. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cologne JB, Tokuoka S, Beebe GW, Fukuhara
T and Mabuchi K: Effects of radiation on incidence of primary liver
cancer among atomic bomb survivors. Radiat Res. 152:364–373. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Preston DL, Ron E, Tokuoka S, Funamoto S,
Nishi N, Soda M, Mabuchi K and Kodama K: Solid cancer incidence in
atomic bomb survivors: 1958–1998. Radiat Res. 168:1–64. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Biermann CW, Fröschle G, Kuhlencordt R,
Schwarz R and Gonnermann D: Bile duct carcinoma after abdominal
irradiation for urologic malignancies. Helv Chir Acta.
60:1131–1136. 1994.(In German). PubMed/NCBI
|
|
22
|
Burmeister BH and Turner SL: External beam
radiation therapy as an agent in the aetiology of carcinoma of the
bile duct: A report on two patients. Clin Oncol (R Coll Radiol).
7:48–49. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cheng JC, Wu JK, Huang CM, Huang DY, Cheng
SH, Lin YM, Jian JJ, Yang PS, Chuang VP and Huang AT:
Radiation-induced liver disease after radiotherapy for
hepatocellular carcinoma: Clinical manifestation and dosimetric
description. Radiother Oncol. 63:41–45. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Greten TF, Manns MP, Reinisch I and
Kaatsch P: Hepatocellular carcinoma occurring after successful
treatment of childhood cancer with high dose chemotherapy and
radiation. Gut. 54:7322005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Cherqui D, Palazzo L, Piedbois P,
Charlotte F, Duvoux C, Duron JJ, Fagniez PL and Valla D: Common
bile duct stricture as a late complication of upper abdominal
radiotherapy. J Hepatol. 20:693–697. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nakakubo Y, Kondo S, Katoh H and Shimizu
M: Biliary stricture as a possible late complication of radiation
therapy. Hepatogastroenterology. 47:1531–1532. 2000.PubMed/NCBI
|
|
27
|
Jaiswal M, LaRusso NF, Burgart LJ and
Gores GJ: Inflammatory cytokines induce DNA damage and inhibit DNA
repair in cholangiocarcinoma cells by a nitric oxide-dependent
mechanism. Cancer Res. 60:184–190. 2000.PubMed/NCBI
|
|
28
|
Schottenfeld D and Beebe-Dimmer J: Chronic
inflammation: A common and important factor in the pathogenesis of
neoplasia. CA Cancer J Clin. 56:69–83. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wise C, Pilanthananond M, Perry BF, Alpini
G, McNeal M and Glaser SS: Mechanisms of biliary carcinogenesis and
growth. World J Gastroenterol. 14:2986–2989. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gorea G, Demy M, van Nhieu J Tran, Tigori
J, Aubé C, Cherqui D, Oberti F, Caroli-Bosc FX and Calès P:
Radiation-induced cholangitis with hepatocellular Carcinoma.
Gastroenterol Clin Biol. 34:35–39. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lawrence TS, Robertson JM, Anscher MS,
Jirtle RL, Ensminger WD and Fajardo LF: Hepatic toxicity resulting
from cancer treatment. Int J Radiat Oncol Biol Phys. 31:1237–1248.
1995. View Article : Google Scholar : PubMed/NCBI
|
